403 related articles for article (PubMed ID: 11544635)
1. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
2. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.
Wesierska-Gadek J; Wang ZQ; Schmid G
Cancer Res; 1999 Jan; 59(1):28-34. PubMed ID: 9892179
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint.
Wesierska-Gadek J; Schmid G
J Cell Biochem; 2000 Sep; 80(1):85-103. PubMed ID: 11029756
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
Wesierska-Gadek J; Schloffer D; Gueorguieva M; Uhl M; Skladanowski A
Cancer Res; 2004 Jul; 64(13):4487-97. PubMed ID: 15231658
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.
Wesierska-Gadek J; Wojciechowski J; Schmid G
J Cell Biochem; 2003 Aug; 89(6):1260-84. PubMed ID: 12898523
[TBL] [Abstract][Full Text] [Related]
6. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein.
Wurzer G; Herceg Z; Wesierska-Gadek J
Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636
[TBL] [Abstract][Full Text] [Related]
7. Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1.
Schmid G; Wojciechowski J; Wesierska-Gadek J
Acta Biochim Pol; 2005; 52(3):713-9. PubMed ID: 16082409
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.
David-Pfeuty T; Chakrani F; Ory K; Nouvian-Dooghe Y
Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102
[TBL] [Abstract][Full Text] [Related]
9. Integrin-mediated suppression of endotoxin-induced DNA damage in lung endothelial cells is sensitive to poly(ADP-ribose) polymerase-1 gene deletion.
Huang H; McIntosh JL; Fang L; Szabo C; Hoyt DG
Int J Mol Med; 2003 Oct; 12(4):533-40. PubMed ID: 12964031
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
11. Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.
Lövborg H; Wojciechowski J; Larsson R; Wesierska-Gadek J
Cancer Res; 2002 Aug; 62(15):4206-11. PubMed ID: 12154020
[TBL] [Abstract][Full Text] [Related]
12. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
13. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
14. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
Kameoka M; Tanaka Y; Ota K; Itaya A; Yoshihara K
Biochem Biophys Res Commun; 1999 Aug; 262(1):285-9. PubMed ID: 10448106
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
[TBL] [Abstract][Full Text] [Related]
16. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
Bissonnette N; Wasylyk B; Hunting DJ
Biochem Cell Biol; 1997; 75(4):351-8. PubMed ID: 9493957
[TBL] [Abstract][Full Text] [Related]
17. ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.
Wesierska-Gadek J; Schmid G; Cerni C
Biochem Biophys Res Commun; 1996 Jul; 224(1):96-102. PubMed ID: 8694840
[TBL] [Abstract][Full Text] [Related]
18. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
[TBL] [Abstract][Full Text] [Related]
19. p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents.
Grombacher T; Eichhorn U; Kaina B
Oncogene; 1998 Aug; 17(7):845-51. PubMed ID: 9780001
[TBL] [Abstract][Full Text] [Related]
20. The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
De Blasio A; Musmeci MT; Giuliano M; Lauricella M; Emanuele S; D'Anneo A; Vassallo B; Tesoriere G; Vento R
Int J Oncol; 2003 Dec; 23(6):1521-8. PubMed ID: 14612922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
